NR4A1 and breast cancer: At the molecular level, breast cancer molecular signatures include the activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), the activation of hormone receptors (estrogen receptors and progesterone receptors), and BRCA mutations (16, 17).